These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22776842)

  • 81. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
    Ye ZY; Cao YB; Lin TY; Lin HL
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
    [TBL] [Abstract][Full Text] [Related]  

  • 82. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
    Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
    Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
    Rossi D; Gaidano G
    Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
    Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
    Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
    Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
    Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.
    Amen F; Horncastle D; Elderfield K; Banham AH; Bower M; Macdonald D; Kanfer E; Naresh KN
    Histopathology; 2007 Jul; 51(1):70-9. PubMed ID: 17593082
    [TBL] [Abstract][Full Text] [Related]  

  • 87. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 88. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
    Onizuka T; Moriyama M; Yamochi T; Kuroda T; Kazama A; Kanazawa N; Sato K; Kato T; Ota H; Mori S
    Blood; 1995 Jul; 86(1):28-37. PubMed ID: 7795234
    [TBL] [Abstract][Full Text] [Related]  

  • 89. LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage.
    Latchmansingh KA; Wang X; Verdun RE; Marques-Piubelli ML; Vega F; You MJ; Chapman J; Lossos IS
    Mod Pathol; 2022 Sep; 35(9):1220-1226. PubMed ID: 35322192
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Detection of 3q27 chromosomal abnormality in diffuse large B cell lymphoma using FISH on cell microarray].
    Jiang HY; Li HL; Zhao T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):73-7. PubMed ID: 18247310
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 92. Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.
    Richards KL; Motsinger-Reif AA; Chen HW; Fedoriw Y; Fan C; Nielsen DM; Small GW; Thomas R; Smith C; Dave SS; Perou CM; Breen M; Borst LB; Suter SE
    Cancer Res; 2013 Aug; 73(16):5029-39. PubMed ID: 23783577
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.
    Younes SF; Beck AH; Ohgami RS; Lossos IS; Levy R; Warnke RA; Natkunam Y
    Am J Clin Pathol; 2011 May; 135(5):697-708. PubMed ID: 21502424
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.
    Gonin J; Larousserie F; Bastard C; Picquenot JM; Couturier J; Radford-Weiss I; Dietrich C; Brousse N; Vacher-Lavenu MC; Devergne O
    PLoS One; 2011; 6(9):e24617. PubMed ID: 21931777
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.
    Malumbres R; Sarosiek KA; Cubedo E; Ruiz JW; Jiang X; Gascoyne RD; Tibshirani R; Lossos IS
    Blood; 2009 Apr; 113(16):3754-64. PubMed ID: 19047678
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.
    Martinez A; Pittaluga S; Rudelius M; Davies-Hill T; Sebasigari D; Fountaine TJ; Hewitt S; Jaffe ES; Raffeld M
    Am J Surg Pathol; 2008 Aug; 32(8):1190-200. PubMed ID: 18580679
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
    Natkunam Y; Hsi ED; Aoun P; Zhao S; Elson P; Pohlman B; Naushad H; Bast M; Levy R; Lossos IS
    Blood; 2007 Jan; 109(1):298-305. PubMed ID: 16954503
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas.
    Zheng J; Xu J; Ma S; Sun X; Geng M; Wang L
    Int J Clin Exp Pathol; 2013; 6(10):2048-55. PubMed ID: 24133582
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System.
    Omidvar N; Tekin N; Conget P; Bruna F; Timar B; Gagyi E; Basak R; Auewarakul C; Sritana N; Cerci JJ; Dimamay MP; Gyorke T; Redondo F; Nair R; Gorospe C; Paez D; Fanti S; Ozdag H; Padua RA; Carr R
    Acta Haematol; 2020; 143(6):600-602. PubMed ID: 32187599
    [No Abstract]   [Full Text] [Related]  

  • 100. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma.
    Said JW; Hoyer KK; French SW; Rosenfelt L; Garcia-Lloret M; Koh PJ; Cheng TC; Sulur GG; Pinkus GS; Kuehl WM; Rawlings DJ; Wall R; Teitell MA
    Lab Invest; 2001 Apr; 81(4):555-64. PubMed ID: 11304575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.